1654P A phase Ib/II study of the dual MDMX/MDM2 inhibitor, ALRN-6924, for the prevention of chemotherapy-induced myelosuppression
- Resource Type
- Abstract
- Source
- In
Annals of Oncology September 2021 32 Supplement 5:S1166-S1166 - Subject
- Language
- ISSN
- 0923-7534